Keyword

V3 loop

Description: A variable region of the HIV envelope glycoprotein gp120 that contributes to receptor interactions and viral entry.

Primary topic: HIV Research and Treatment (86%)

Related topic: HIV Research and Treatment (86%)

Wikidata ID: wiki/Q7906384

OpenAlex ID: keywords/v3-loop

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

1996 · Lijun Wu, Norma P. Gerard, et al. · Nature · 1,168

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

1996 · Alexandra Trkola, Tatjana Dragic, et al. · Nature · 1,034

Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1

1991 · Stephen S. Hwang, Terence J. Boyle, et al. · Science · 870

A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding

1998 · Carlo D. Rizzuto, Richard Wyatt, et al. · Science · 812

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1992 · R A Fouchier, M Groenink, et al. · Journal of Virology · 771

Structure of a V3-Containing HIV-1 gp120 Core

2005 · Chih-chin Huang, Min Tang, et al. · Science · 731

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

2004 · James M. Binley, Terri Wrin, et al. · Journal of Virology · 705

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

2011 · Robert Pejchal, Katie J. Doores, et al. · Science · 694

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

2013 · Dmitry Lyumkis, Jean-Philippe Julien, et al. · Science · 669

Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

1990 · Gregory J. LaRosa, Joseph P. Davide, et al. · Science · 650

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

1991 · Q J Sattentau, J P Moore · The Journal of Experimental Medicine · 601

Selective Transmission of Human Immunodeficiency Virus Type-1 Variants from Mothers to Infants

1992 · Steven M. Wolinsky, Carla M. Wike, et al. · Science · 586

Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism

1992 · B Chesebro, K Wehrly, et al. · Journal of Virology · 585

PDF

Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

1992 · J J De Jong, A De Ronde, et al. · Journal of Virology · 505

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

1988 · J Goudsmit, C Debouck, et al. · Proceedings of the National Academy of Sciences · 500

The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection

1996 · Florenza Cocchi, Anthony L. DeVico, et al. · Nature Medicine · 495

Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

1994 · A B van't Wout, N A Kootstra, et al. · Journal of Clinical Investigation · 494

PDF

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1992 · E. A. Emini, W. A. Schleif, et al. · Nature · 471

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1

1994 · P Roben, J P Moore, et al. · Journal of Virology · 455

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1995 · R Wyatt, J Moore, et al. · Journal of Virology · 417

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

2002 · Jacqueline D. Reeves, Stephen A. Gallo, et al. · Proceedings of the National Academy of Sciences · 404

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

1994 · L G Gürtler, P H Hauser, et al. · Journal of Virology · 391

Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

2008 · James M. Binley, Elizabeth A. Lybarger, et al. · Journal of Virology · 355

Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1

1990 · Kashi Javaherian, Alphonse J. Langlois, et al. · Science · 353

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.

1995 · Q J Sattentau, J P Moore · The Journal of Experimental Medicine · 334

Works count: 2,313

Citation count: 77,500